Creative Proteomics provides N-terminal sequence analysis by both Edman and Mass spectrometry of therapeutic proteins, monoclonal antibodies and protein vaccines. Creative Proteomics, as an experienced drug development services supplier, has been well equipped with advanced technologies and services in proteomics field, in order to meet the increasing needs from researchers and scientists in their proteomics related researches.
With extensive experienced scientists and experts, Creative Proteomics can offer the high-quality products and services, such as protein identification, protein biomarker quantification, stable isotope labeled products and so on for its customers.